amlodipine 1 MG/ML Oral Suspension [Katerzia]
amlodipine
RxCUI: 2184126
What the CMS Formulary Data Shows for amlodipine 1 MG/ML Oral Suspension [Katerzia]
Per the CMS 2026 Part D formulary file, amlodipine 1 MG/ML Oral Suspension [Katerzia] (RxNorm concept RXCUI 2184126, generic name amlodipine) appears on 6 distinct formulary files spanning 22 Medicare Part D plan offerings - 0.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.2.
Real-world access to amlodipine 1 MG/ML Oral Suspension [Katerzia] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 100% require step therapy. 100% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 11,575,402 Part D beneficiaries filled amlodipine 1 MG/ML Oral Suspension [Katerzia] in 2023, with total plan-and-beneficiary spending of $407,233,375 and an average per-beneficiary annual cost of $35.18. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry amlodipine 1 MG/ML Oral Suspension [Katerzia] today.
Coverage Details
- Formularies covering
- 6
- Plans covering
- 22
- Coverage rate
- 0.4%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 100% of formularies
- Quantity limits
- 100% of formularies
2023 Medicare Spending
- Beneficiaries
- 11,575,402
- Total spending
- $407,233,375
- Avg per beneficiary
- $35.18
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering amlodipine 1 MG/ML Oral Suspension [Katerzia]
22 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | GOLD KIDNEY OF FLORIDA INC | T1 | No | $4.80 | FL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | GOLD KIDNEY OF ARIZONA | T1 | No | $17.00 | AZ |
| PHP (HMO C-SNP) | AIDS HEALTHCARE FOUNDATION | T3 | No | $0 | CA |
| VNS Health Total (HMO D-SNP) | VNS CHOICE | T3 | No | $0 | NY |
| VNS Health EasyCare Plus (HMO D-SNP) | VNS CHOICE | T3 | No | $51.60 | NY |
| SummaCare Medicare Topaz (HMO) | SUMMACARE INC. | T4 | No | $0 | OH |
| SummaCare Medicare Quartz (HMO) | SUMMACARE INC. | T4 | No | $0 | OH |
| Gold Heart & Diabetes (HMO-POS C-SNP) | GOLD KIDNEY OF FLORIDA INC | T4 | No | $0 | FL |
| Gold Heart & Diabetes Complete (HMO-POS C-SNP) | GOLD KIDNEY OF FLORIDA INC | T4 | No | $0 | FL |
| Gold Dialysis & Kidney (HMO-POS C-SNP) | GOLD KIDNEY OF FLORIDA INC | T4 | No | $0 | FL |
| Gold Health (HMO-POS C-SNP) | GOLD KIDNEY OF FLORIDA INC | T4 | No | $0 | FL |
| Gold Dialysis & Kidney (HMO-POS C-SNP) | GOLD KIDNEY OF FLORIDA INC | T4 | No | $0 | FL |
| Gold Heart & Diabetes (HMO-POS C-SNP) | GOLD KIDNEY OF ARIZONA | T4 | No | $0 | AZ |
| Gold Dialysis & Kidney (HMO-POS C-SNP) | GOLD KIDNEY OF ARIZONA | T4 | No | $0 | AZ |
| Gold Heart & Diabetes (HMO-POS C-SNP) | GOLD KIDNEY OF ARIZONA | T4 | No | $0 | AZ |
| Gold Dialysis & Kidney (HMO-POS C-SNP) | GOLD KIDNEY OF ARIZONA | T4 | No | $0 | AZ |
| VillageCareMAX Medicare Health Advantage Plan (HMO D-SNP) | VILLAGE SENIOR SERVICES CORPORATION | T4 | No | $0 | NY |
| VillageCareMAX Medicare Total Advantage Plan (HMO D-SNP) | VILLAGE SENIOR SERVICES CORPORATION | T4 | No | $0 | NY |
| SummaCare Medicare Garnet (HMO) | SUMMACARE INC. | T4 | No | $35.00 | OH |
| SummaCare Medicare Ruby (HMO) | SUMMACARE INC. | T4 | No | $50.00 | OH |
| SummaCare Medicare Sapphire (HMO-POS) | SUMMACARE INC. | T4 | No | $83.00 | OH |
| SummaCare Medicare Emerald (HMO-POS) | SUMMACARE INC. | T4 | No | $100.80 | OH |
Frequently Asked Questions
Is amlodipine 1 MG/ML Oral Suspension [Katerzia] covered by Medicare Part D?
Yes, amlodipine 1 MG/ML Oral Suspension [Katerzia] is covered by 22 Medicare Part D plans (0.4% of all Part D formularies).
What tier is amlodipine 1 MG/ML Oral Suspension [Katerzia] on Medicare Part D plans?
amlodipine 1 MG/ML Oral Suspension [Katerzia] averages Tier 3.2 across Part D plans, ranging from Tier 1 to Tier 4.
Does amlodipine 1 MG/ML Oral Suspension [Katerzia] require prior authorization?
0% of Part D formularies require prior authorization for amlodipine 1 MG/ML Oral Suspension [Katerzia]. Step therapy: 100%. Quantity limits: 100%.
How much does Medicare spend on amlodipine 1 MG/ML Oral Suspension [Katerzia]?
In 2023, total Medicare Part D spending on amlodipine 1 MG/ML Oral Suspension [Katerzia] was $407,233,375, covering 11,575,402 beneficiaries. The average spend per beneficiary was $35.18.
Read our methodology - how this data is sourced, computed, and verified.